Lake Point Wealth Management’s Integra LifeSciences IART Stock Holding History

Lake Point Wealth Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$7K	Hold	137	–	–	﹤0.01%	191
2022 Q1	$9K	Hold	137	–	–	﹤0.01%	177
2021 Q4	$9K	Buy	+137	New	+$9.27K	﹤0.01%	187

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lake Point Wealth Management's IART Position: Q2 2022 in Review

Lake Point Wealth Management held its Integra LifeSciences (IART) position steady in Q2 2022 at 137 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #191.

Lake Point Wealth Management first reported a position in IART in Q4 2021 and has held it in 3 quarters since. The position peaked at $9K in Q1 2022. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

Lake Point Wealth Management held 137 shares of Integra LifeSciences worth $7K as of Q2 2022.
Lake Point Wealth Management left its Integra LifeSciences share count unchanged in Q2 2022.
Integra LifeSciences made up ﹤0.01% of Lake Point Wealth Management's portfolio in Q2 2022, its #191 holding.
Lake Point Wealth Management first reported a position in Integra LifeSciences in Q4 2021 and has held it in 3 quarters since.
Lake Point Wealth Management's Integra LifeSciences position peaked at $9K in Q1 2022.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Lake Point Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.